Our "insight" early data release at ASCO will be of interest to many....Avelumab has a rap sheet
as long as your arm in regard to side effects but it has approval due to scarcity of other treatments
available...Very small trial and wont effect the market in my mind but we will see....
- Forums
- ASX - By Stock
- IMM
- Ann: INSIGHT-004 and TACTI-002 data to be presented at ASCO
Ann: INSIGHT-004 and TACTI-002 data to be presented at ASCO, page-14
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
30.0¢ |
Change
-0.020(6.25%) |
Mkt cap ! $435.7M |
Open | High | Low | Value | Volume |
31.5¢ | 31.5¢ | 29.5¢ | $2.355M | 7.796M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 128197 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 128197 | 0.295 |
19 | 601843 | 0.290 |
15 | 178898 | 0.285 |
23 | 1297758 | 0.280 |
6 | 183301 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 100000 | 1 |
0.305 | 126168 | 4 |
0.310 | 157018 | 5 |
0.315 | 28000 | 2 |
0.320 | 82625 | 5 |
Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |